血流感染検査の世界市場レポート 2025年

血流感染検査の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR11.7％で131億9,000万米ドルに成長します。予測期間の成長は、迅速診断検査に対する需要の増加、分子診断の採用拡大、個別化医療への注目の高まり、感染制御に対する政府の取り組み、多剤耐性病原体の有病率の上昇などに起因すると考えられます。予測期間における主な動向としては、診断ツールにおけるAIの利用拡大、遠隔医療と診断サービスの統合、在宅検査キットの需要拡大、マルチプレックス診断プラットフォームの開発、診断企業と病院間のパートナーシップの拡大などが挙げられます。

感染症の流行の高まりは、血流感染検査市場の今後の成長を促進すると予測されています。感染症は、細菌、ウイルス、真菌、寄生虫などの病原性微生物によって引き起こされる病気と定義されます。感染症の発生率は、世界の旅行者の増加、都市化、気候変動、抗生物質耐性、ワクチン接種範囲のギャップなど、いくつかの要因によって増加しています。血流感染症の治療は、敗血症やその他の重篤な感染症の原因となる病原体を診断・特定し、的を絞った効果的な治療を可能にする上で極めて重要です。例えば、スイスに本部を置く国連機関、世界保健機関（WHO）が2023年12月に発表した最新の世界マラリア報告書によると、2022年のマラリア患者数は2億4,900万人で、2021年の2億4,400万人から増加しています。マラリアに関連した推定死亡者数は、2021年の61万人に対し、2022年は60万8,000人でした。このように、感染症の流行の増加が血流感染検査市場を牽引しています。

血流感染検査市場の主な企業は、特に血液検査用カートリッジの開発によって、市場での地位を維持するために製品の技術革新に注力しています。これらの使い捨てデバイスは、診断検査中に血液サンプルを分析するように設計されており、あらかじめ装填された試薬と、少量の血液サンプルから特定のバイオマーカー、病原体、または状態を検出するのに役立つ統合センサーまたはマイクロ流体チャンネルが含まれています。例えば、2022年8月、オーストラリアの分子診断会社Immunexpress Pty Ltd.はSeptiCyte RAPIDカートリッジを発表しました。これらのカートリッジは、エチレンジアミン四酢酸（EDTA）原液を有効なサンプルタイプとして利用するもので、欧州のマルチサイト研究で他の採血方法と強い相関性を示しました。この技術革新により、敗血症診断の精度とスピードが向上し、より広範な臨床利用が促進され、ヘルスケアコストを削減しながら患者ケアを変革する可能性があります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界血流感染検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の血流感染検査市場：成長率分析
• 世界の血流感染検査市場の実績：規模と成長, 2019-2024
• 世界の血流感染検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界血流感染検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の血流感染検査市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 機器
• 試薬および消耗品
• ソフトウェアとサービス
• 世界の血流感染検査市場サンプルタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 全血
• 血液培養
• 世界の血流感染検査市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポリメラーゼ連鎖反応（PCR）
• 質量分析
• インサイチューハイブリダイゼーション
• その他のテクノロジー
• 世界の血流感染検査市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診断センター
• 検査サービスプロバイダー
• 学術研究機関
• その他のエンドユーザー
• 世界の血流感染検査市場、楽器の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液培養システム
• 自動微生物同定システム
• 分子診断機器
• 世界の血流感染検査市場試薬および消耗品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液培養培地
• 抗菌薬感受性試験試薬
• 核酸抽出キット
• 世界の血流感染検査市場ソフトウェアとサービスのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 検査情報管理システム（LIMS）
• データ分析ソフトウェア
• メンテナンスおよびサポートサービス

第7章 地域別・国別分析

• 世界の血流感染検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の血流感染検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 血流感染検査市場：競合情勢
• 血流感染検査市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthcare Private Limited Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Becton Dickinson and Company（BD）
• Grifols S.A.
• Hologic Inc.
• BIOMERIEUX SA
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• Qiagen N.V.
• DiaSorin S.p.A.
• Seegene Inc.
• Cepheid
• Meridian Bioscience Inc.
• Biocartis NV
• T2 Biosystems Inc.
• Molzym GmbH & Co. KG
• Curetis GmbH

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 血流感染検査市場2029：新たな機会を提供する国
• 血流感染検査市場2029：新たな機会を提供するセグメント
• 血流感染検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Bloodstream infection testing involves diagnostic methods used to detect and identify pathogens such as bacteria, fungi, or viruses in the blood that lead to infections. This process typically includes blood cultures and molecular assays to pinpoint the specific microorganism causing the infection. Accurate and timely detection is essential for the effective treatment and management of conditions such as sepsis and other severe infections.

The primary product categories in bloodstream infection testing include instruments, reagents and consumables, and software and services. Instruments used in bloodstream infection testing refer to the specialized equipment and devices designed to detect and analyze pathogens in blood samples, facilitating precise diagnosis and infection monitoring. Testing is performed on samples such as whole blood or blood cultures, employing technologies such as polymerase chain reaction (PCR), mass spectrometry, in situ hybridization, and others. The end-users of this testing include hospitals and diagnostic centers, laboratory service providers, academic and research institutions, and more.

The blood stream infection testing market research report is one of a series of new reports from The Business Research Company that provides blood stream infection testing market statistics, including blood stream infection testing industry global market size, regional shares, competitors with a blood stream infection testing market share, detailed blood stream infection testing market segments, market trends and opportunities, and any further data you may need to thrive in the blood stream infection testing industry. This blood stream infection testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood stream infection testing market size has grown rapidly in recent years. It will grow from $7.59 billion in 2024 to $8.49 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to the rising incidence of hospital-acquired infections, growing prevalence of antimicrobial resistance, increasing aging population, increasing healthcare expenditure, and rising prevalence of chronic diseases.

The blood stream infection testing market size is expected to see rapid growth in the next few years. It will grow to $13.19 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostic tests, growing adoption of molecular diagnostics, rising focus on personalized medicine, government initiatives for infection control, and rising prevalence of multi-drug-resistant pathogens. Major trends in the forecast period include the growing use of AI in diagnostic tools, integration of telemedicine with diagnostic services, rising demand for home-based testing kits, development of multiplex diagnostic platforms, and growing partnerships between diagnostic companies and hospitals.

The rising prevalence of infectious diseases is projected to drive the growth of the bloodstream infection testing market in the future. Infectious diseases are defined as illnesses caused by pathogenic microorganisms, including bacteria, viruses, fungi, or parasites. The rates of infectious diseases are increasing due to several factors, such as heightened global travel, urbanization, climate change, antibiotic resistance, and gaps in vaccination coverage. Testing for bloodstream infections is crucial in diagnosing and identifying pathogens responsible for sepsis and other severe infections, enabling targeted and effective treatment. For example, in December 2023, the latest World Malaria Report published by the World Health Organization (WHO), a Switzerland-based United Nations agency, indicated that there were 249 million cases of malaria in 2022, up from 244 million cases in 2021. The estimated number of malaria-related deaths was 608,000 in 2022, compared to 610,000 in 2021. Thus, the increasing prevalence of infectious diseases is driving the bloodstream infection testing market.

Key companies in the bloodstream infection testing market are focusing on product innovation to maintain their market position, particularly by developing blood testing cartridges. These disposable devices are designed to analyze blood samples during diagnostic tests, containing preloaded reagents and integrated sensors or microfluidic channels that help detect specific biomarkers, pathogens, or conditions from a small blood sample. For instance, in August 2022, Immunexpress Pty Ltd., an Australian molecular diagnostics company, introduced SeptiCyte RAPID cartridges. These cartridges utilize undiluted ethylenediaminetetraacetic acid (EDTA) blood as a validated sample type, showing a strong correlation with other blood collection methods in a multi-site European study. This innovation enhances the accuracy and speed of sepsis diagnosis, promoting broader clinical use and potentially transforming patient care while reducing healthcare costs.

In January 2023, Thermo Fisher Scientific Inc., a U.S.-based life science and clinical research company, acquired Binding Site Group Ltd. for $2.8 billion. The acquisition aims to strengthen Thermo Fisher's specialty diagnostics segment by incorporating Binding Site's innovative technologies for diagnosing and monitoring multiple myeloma, enhancing clinical value, accelerating patient outcomes, and contributing to the growth of the diagnostics market. Binding Site Group Ltd., based in the UK, manufactures medical diagnostic products focused on detecting cancer and immune disorders.

Major companies operating in the blood stream infection testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Danaher Corporation, Siemens Healthcare Private Limited, Becton Dickinson and Company (BD), Grifols S.A., Hologic Inc., BIOMERIEUX SA, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., DiaSorin S.p.A., Seegene Inc., Cepheid, Meridian Bioscience Inc., Biocartis NV, T2 Biosystems Inc., Molzym GmbH & Co. KG, Curetis GmbH, Accelerate Diagnostics Inc., OpGen Inc.

North America was the largest region in the blood stream infection testing market in 2024. The regions covered in the blood stream infection testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the blood stream infection testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The blood stream infection testing market consists of revenues earned by entities by providing services such as molecular diagnostics, serological assays, rapid diagnostic tests, next-generation sequencing, and pathogen identification and sensitivity testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood stream infection testing market also includes sales of blood culture media, molecular diagnostics kits, rapid diagnostic tests, automated blood culture systems, microbial identification panels, sepsis biomarker assays, and immunoassay kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Stream Infection Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood stream infection testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blood stream infection testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blood stream infection testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Instruments; Reagents And Consumables; Software And Services
• 2) By Sample Type: Whole Blood; Blood Culture
• 3) By Technology: Polymerase Chain Reaction (PCR); Mass Spectroscopy; In Situ Hybridization; Other Technologies
• 4) By End-User: Hospitals And Diagnostic Centers; Laboratory Service Providers; Academic And Research Institutes; Other End-Users
• Subsegments:
• 1) By Instruments: Blood Culture Systems; Automated Microbial Identification Systems; Molecular Diagnostic Instruments
• 2) By Reagents and Consumables: Blood Culture Media; Antimicrobial Susceptibility Testing Reagents; Nucleic Acid Extraction Kits
• 3) By Software and Services: Laboratory Information Management Systems (LIMS); Data Analysis Software; Maintenance And Support Services
• Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; F. Hoffmann-La Roche Ltd; Danaher Corporation; Siemens Healthcare Private Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Blood Stream Infection Testing Market Characteristics

3. Blood Stream Infection Testing Market Trends And Strategies

4. Blood Stream Infection Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Blood Stream Infection Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Blood Stream Infection Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Blood Stream Infection Testing Market Growth Rate Analysis
• 5.4. Global Blood Stream Infection Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Blood Stream Infection Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Blood Stream Infection Testing Total Addressable Market (TAM)

6. Blood Stream Infection Testing Market Segmentation

• 6.1. Global Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments
• Reagents And Consumables
• Software And Services
• 6.2. Global Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Whole Blood
• Blood Culture
• 6.3. Global Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction (PCR)
• Mass Spectroscopy
• In Situ Hybridization
• Other Technologies
• 6.4. Global Blood Stream Infection Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Diagnostic Centers
• Laboratory Service Providers
• Academic And Research Institutes
• Other End-Users
• 6.5. Global Blood Stream Infection Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Culture Systems
• Automated Microbial Identification Systems
• Molecular Diagnostic Instruments
• 6.6. Global Blood Stream Infection Testing Market, Sub-Segmentation Of Reagents and Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Culture Media
• Antimicrobial Susceptibility Testing Reagents
• Nucleic Acid Extraction Kits
• 6.7. Global Blood Stream Infection Testing Market, Sub-Segmentation Of Software and Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Information Management Systems (LIMS)
• Data Analysis Software
• Maintenance And Support Services

7. Blood Stream Infection Testing Market Regional And Country Analysis

• 7.1. Global Blood Stream Infection Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Blood Stream Infection Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Blood Stream Infection Testing Market

• 8.1. Asia-Pacific Blood Stream Infection Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Blood Stream Infection Testing Market

• 9.1. China Blood Stream Infection Testing Market Overview
• 9.2. China Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Blood Stream Infection Testing Market

• 10.1. India Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Blood Stream Infection Testing Market

• 11.1. Japan Blood Stream Infection Testing Market Overview
• 11.2. Japan Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Blood Stream Infection Testing Market

• 12.1. Australia Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Blood Stream Infection Testing Market

• 13.1. Indonesia Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Blood Stream Infection Testing Market

• 14.1. South Korea Blood Stream Infection Testing Market Overview
• 14.2. South Korea Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Blood Stream Infection Testing Market

• 15.1. Western Europe Blood Stream Infection Testing Market Overview
• 15.2. Western Europe Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Blood Stream Infection Testing Market

• 16.1. UK Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Blood Stream Infection Testing Market

• 17.1. Germany Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Blood Stream Infection Testing Market

• 18.1. France Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Blood Stream Infection Testing Market

• 19.1. Italy Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Blood Stream Infection Testing Market

• 20.1. Spain Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Blood Stream Infection Testing Market

• 21.1. Eastern Europe Blood Stream Infection Testing Market Overview
• 21.2. Eastern Europe Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Blood Stream Infection Testing Market

• 22.1. Russia Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Blood Stream Infection Testing Market

• 23.1. North America Blood Stream Infection Testing Market Overview
• 23.2. North America Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Blood Stream Infection Testing Market

• 24.1. USA Blood Stream Infection Testing Market Overview
• 24.2. USA Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Blood Stream Infection Testing Market

• 25.1. Canada Blood Stream Infection Testing Market Overview
• 25.2. Canada Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Blood Stream Infection Testing Market

• 26.1. South America Blood Stream Infection Testing Market Overview
• 26.2. South America Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Blood Stream Infection Testing Market

• 27.1. Brazil Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Blood Stream Infection Testing Market

• 28.1. Middle East Blood Stream Infection Testing Market Overview
• 28.2. Middle East Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Blood Stream Infection Testing Market

• 29.1. Africa Blood Stream Infection Testing Market Overview
• 29.2. Africa Blood Stream Infection Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Blood Stream Infection Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Blood Stream Infection Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Blood Stream Infection Testing Market Competitive Landscape And Company Profiles

• 30.1. Blood Stream Infection Testing Market Competitive Landscape
• 30.2. Blood Stream Infection Testing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens Healthcare Private Limited Overview, Products and Services, Strategy and Financial Analysis

31. Blood Stream Infection Testing Market Other Major And Innovative Companies

• 31.1. Becton Dickinson and Company (BD)
• 31.2. Grifols S.A.
• 31.3. Hologic Inc.
• 31.4. BIOMERIEUX SA
• 31.5. Bio-Rad Laboratories Inc.
• 31.6. Bruker Corporation
• 31.7. Qiagen N.V.
• 31.8. DiaSorin S.p.A.
• 31.9. Seegene Inc.
• 31.10. Cepheid
• 31.11. Meridian Bioscience Inc.
• 31.12. Biocartis NV
• 31.13. T2 Biosystems Inc.
• 31.14. Molzym GmbH & Co. KG
• 31.15. Curetis GmbH

32. Global Blood Stream Infection Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blood Stream Infection Testing Market

34. Recent Developments In The Blood Stream Infection Testing Market

35. Blood Stream Infection Testing Market High Potential Countries, Segments and Strategies

• 35.1 Blood Stream Infection Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Blood Stream Infection Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Blood Stream Infection Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250423_r33444_Blood_Stream_Infection_Testing_GMR_2025